MetLife Inc

MetLife’s steady stock, China tax‑advantaged care launch and ESG‑focused philanthropy highlight its resilience, global growth strategy and appeal to institutional investors.

Discover how MetLife’s data‑driven underwriting, AI‑powered risk models, and blockchain claims tech are reshaping U.S. life‑insurance pricing and resilience.

MetLife’s Q4 2025 earnings highlight strong global growth, diversified products and a “Buy” analyst rating, pointing to steady shareholder value and disciplined risk‑management strategies.

MetLife’s stock faces mixed analyst views as Wells Fargo hikes its target—insights into margin compression, fintech pressure, and the need for transparent data.

MetLife’s upgraded valuation and new Irish employee‑benefits launch show strong digital growth, robust capital and a bold push into Europe and APAC.

MetLife’s February earnings call: investors eye capital use, dividend health and underwriting trends amid stable but shifting insurance dynamics.

Explore MetLife’s 2026 strategy: rating downgrade, Irish expansion, and Indian partnership, and learn how the insurer balances growth, risk, and regulation.

MetLife’s $430 million Q4 2024 buyback and 2025 outlook reveal cash‑flow limits, investment‑income volatility and capital‑management gaps, urging deeper scrutiny.

MetLife’s bold 8‑million‑share buyback, backed by strong earnings and $6.2 B free cash flow, shows how insurers are prioritizing shareholder value while navigating capital‑adequacy risks.

MetLife’s Mizuho “Out‑Performance” rating shows why the insurer’s diversified product mix, strong capital and global reach keep it ahead in a shifting life‑insurance market.